PHARMATEAM INVEST financials
A multi-period view of the public annual-account figures reported for PHARMATEAM INVEST, with comparable measures and links to available source documents.
Company overviewRegistry number
0870188780
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 29, 2026
Financial evidence
Latest movements for PHARMATEAM INVEST
2025 versus 2024
- Operating line
- €630,000
- EBITDA
- €66,118
- Total assets
- €1,102,798
- Equity
- -€25,432
+5%
+255%
+2%
+6.8%
EBITDA margin +10.5% · Equity ratio -2.3%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Revenue | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €630,000 | €66,118 | €1,102,798 | -€25,432 | - |
| 202431 Dec 2024 | €600,000 | €18,623 | €1,081,347 | -€27,294 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.